Abstract
I am not a psychiatrist. I am an internist and a medical geneticist who has become interested in the question of the use of large doses of vitamins in the therapy of schizophrenia because of my involvement with a number of inherited metabolic diseases which I would like to tell you about briefly. In 1954, Hunt and his colleagues described two female siblings with neonatal convulsions whose seizure disorder was not controlled by the usually prescribed anticonvulsants or by physiologic doses of pyridoxine. When these girls were given 10 to 20 times the physiologic requirement, however, seizures stopped abruptly and recurred only after cessation of the pyridoxine supplements. This pattern of seizure control by large amounts of pyridoxine followed by exacerbation after vitamin withdrawal led Hunt to propose that these children were “dependent” on increased amounts of pyridoxine to prevent central nervous system hyperactivity. Thus, the concept of vitamin-dependent metabolic disorders was born. It is interesting, I think, to note that Hunt’s study was reported at about the same time that Dr. Osmond first suggested that nicotinic acid was beneficial in schizophrenia. Since these early observations, the two fields of “vitamin-responsive” or “vitamin-dependent” inborn metabolic disorders and so-called “megavitamin-responsive” schizophrenia have followed very divergent courses. I shall underscore this divergence by first summarizing the pattern of investigation followed in the vitamin-responsive inborn errors of metabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Freeman, J. M., Finkelstein, J. D., Mudd, S. H., and Uhlendorf, B. W., 1972, “Homocystinuria presenting as reversible schizophrenia-a new defect in menthionine metabolism and reduced methylenetetrahydrofolate-reductase activity,” Pediat. Res. 6: 163 (abstract).
Hunt, A. D. Jr., Stokes, J. Jr., McCrory, W. W., and Stroud, H. H., 1954, “Pyridoxine dependency: Report of a case of intractable convulsions in an infant controlled by pyridoxine,” Pediatrics, 13: 140–145.
Mudd, S. H., Uhlendorf, B. W., Freeman, J. M., Finkelstein, J. D., and Shih, V. E., 1972, “Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity,” Biochem. Biophys. Res. Commun 46: 905–912.
Rosenberg, L. E., 1973, “Vitamin dependent genetic disease,” in: Medical Genetics ( V. A. McKusick and R. Claiborne, eds.) pp. 73–79, H. P. Press, New York.
Scriver, C. R., and Rosenberg, L. E., 1973, “Vitamin-responsive aminoacidopathies,” in: Amino Acid Metabolism and Its Disorders, pp. 453–478, Saunders, Philadelphia.
Scriver, C. R., and Whelan, D. T., 1969, “Glutamic acid decarboxylase (GAD) in mammalian tissue outside the central nervous system, and its possible relevance to hereditary vitamin B6 dependency with seizures,” Ann. N.Y. Acad. Sci. 166: 83–96.
Yoshida, T., Tada, K., and Arakawa, T., 1971, “Vitamin B6 dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B6-dependent convulsion,” Tohoku J. Exp. Med. 104: 195–198.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Rosenberg, L.E. (1975). Contrast between Vitamin-Responsive Inherited Metabolic Diseases and Vitamin Use in Schizophrenia. In: Serban, G. (eds) Nutrition and Mental Functions. Advances in Behavioral Biology, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3075-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3075-2_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3077-6
Online ISBN: 978-1-4684-3075-2
eBook Packages: Springer Book Archive